A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF NEBULIZED PC945 WHEN ADDED TO SYSTEMIC ANTIFUNGAL THERAPY FOR THE TREATMENT OF REFRACTORY INVASIVE PULMONARY ASPERGILLOSIS
- Registry ID
- PC_ASP_006
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Study type
- INTERVENTIONAL
- Sponsor
- PULMOCIDE LTD
- Start date
- 2025-01-22
- Completion date
- 2026-01-30
- Last update
- 2022-06-01
Conditions
- INVASIVE PULMONARY ASPERGILLOSIS
View on source registry